Treatment of Neonatal Thrombocytopenia in Infant Born to Mother with SLE

Immediate Management Approach

Neonates with platelet counts <20,000/µL require treatment, particularly if there is clinical hemorrhage, according to the American Society of Hematology 1
The American Academy of Pediatrics recommends platelet transfusion should be administered concurrently with IVIG, especially in severely thrombocytopenic neonates with counts this low 1

The American College of Radiology recommends transcranial ultrasonography should be performed on all neonates with platelet counts <50,000/µL to detect intracranial hemorrhage 1
The American Academy of Pediatrics advises to avoid intramuscular injections (including vitamin K) until platelet count is confirmed and treatment initiated 1
The American Society of Hematology suggests neonatal platelet counts typically nadir between days 2-5 after birth, so close monitoring for 5-7 days is essential 1, 4

The American College of Rheumatology notes that this neonate likely has passive transfer of maternal antiplatelet antibodies from the mother's autoimmune condition 1

The American Academy of Pediatrics recommends not to delay treatment waiting for "observation" - a platelet count of 18,000/µL with maternal autoimmune disease requires immediate intervention 1
The American Society of Hematology advises not to rely on steroids alone - they work too slowly for this acute, severe presentation 2